Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:836-841

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sundström, J.
Right arrow Articles by Lithell, H. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sundström, J.
Right arrow Articles by Lithell, H. O.
Related Collections
Right arrow Lipids
Right arrow Obesity
Right arrow Hypertrophy
Right arrow Epidemiology

(Circulation. 2001;103:836.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Dyslipidemia and an Unfavorable Fatty Acid Profile Predict Left Ventricular Hypertrophy 20 Years Later

Johan Sundström, MD; Lars Lind, MD, PhD; Bengt Vessby, MD, PhD; Bertil Andrén, MD, PhD; Antti Aro, MD, PhD; Hans O. Lithell, MD, PhD

From the Departments of Public Health and Caring Sciences (J.S., B.V., H.O.L.) and Medical Sciences (L.L., B.A.), Uppsala University, Sweden, and Department of Nutrition (A.A.), KTL (National Public Health Institute), Helsinki, Finland.

Correspondence to Johan Sundström, Department of Public Health and Caring Sciences/Geriatrics, PO Box 609, SE-75125 Uppsala, Sweden (Kålsängsgränd 10D, SE-75319 Uppsala, Sweden). E-mail johan.sundstrom{at}geriatrik.uu.se

Background—Left ventricular hypertrophy (LVH) is a common risk factor for cardiovascular mortality. Causes other than hypertension have not previously been investigated longitudinally. The aim of the present study was to determine hemodynamic, metabolic, and psychosocial predictors at 50 years of age for the prevalence of echocardiographic LVH and geometric subtypes at age 70 by use of a large sample of men from the general population followed up for 20 years.

Methods and Results—In 1970 to 1973, all men born from 1920 to 1924 and residing in Uppsala County, Sweden, were invited to participate in a health survey aimed at identifying risk factors for cardiovascular disease. At a reinvestigation 20 years later, echocardiographic left ventricular mass index was determined in 475 subjects. A 1-SD increase in body mass index, systolic or diastolic blood pressure, fasting LDL/HDL cholesterol, serum triglycerides, or the serum cholesterol ester proportion of several saturated fatty acids or oleic acid at age 50 significantly increased the odds of having LVH at age 70 by 27% to 41%, whereas an increase in linoleic acid proportion was protective. Almost all metabolic predictors were independent of ischemic heart disease, valvular disease, and use of antihypertensive medication at age 70.

Conclusions—Dyslipidemia and indices of a low dietary intake of linoleic acid and high intake of saturated and monounsaturated fats, as well as hypertension and obesity, at age 50 predicted the prevalence of LVH 20 years later in this prospective longitudinal cohort study, thereby suggesting that lipids may be important in the origin of LVH.


Key Words: hypertrophy • lipids • fatty acids • insulin • epidemiology




This article has been cited by other articles:


Home page
QJMHome page
J. Sanchez-Quinones, F. Marin, V. Roldan, and G.Y.H. Lip
The impact of statin use on atrial fibrillation
QJM, November 1, 2008; 101(11): 845 - 861.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
N. Martinelli, D. Girelli, G. Malerba, P. Guarini, T. Illig, E. Trabetti, M. Sandri, S. Friso, F. Pizzolo, L. Schaeffer, et al.
FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease
Am. J. Clinical Nutrition, October 1, 2008; 88(4): 941 - 949.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. Warensjo, J. Sundstrom, B. Vessby, T. Cederholm, and U. Riserus
Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study
Am. J. Clinical Nutrition, July 1, 2008; 88(1): 203 - 209.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. R. Heckbert, W. Post, G. D.N. Pearson, D. K. Arnett, A. S. Gomes, M. Jerosch-Herold, W. G. Hundley, J. A. Lima, and D. A. Bluemke
Traditional Cardiovascular Risk Factors in Relation to Left Ventricular Mass, Volume, and Systolic Function by Cardiac Magnetic Resonance Imaging: The Multiethnic Study of Atherosclerosis
J. Am. Coll. Cardiol., November 8, 2006; (2006) j.jacc.2006.03.072v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. Warensjo, J. Sundstrom, L. Lind, and B. Vessby
Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men.
Am. J. Clinical Nutrition, August 1, 2006; 84(2): 442 - 448.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
G. Foldes, S. Vajda, Z. Lako-Futo, B. Sarman, R. Skoumal, M. Ilves, R. deChatel, I. Karadi, M. Toth, H. Ruskoaho, et al.
Distinct modulation of angiotensin II-induced early left ventricular hypertrophic gene programming by dietary fat type
J. Lipid Res., June 1, 2006; 47(6): 1219 - 1226.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. Lubos, R. Schnabel, H. J. Rupprecht, C. Bickel, C. M. Messow, S. Prigge, F. Cambien, L. Tiret, T. Munzel, and S. Blankenberg
Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene study
Eur. Heart J., January 2, 2006; 27(2): 150 - 156.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T.-M. Lee, M.-S. Lin, T.-F. Chou, and N.-C. Chang
Effect of simvastatin on left ventricular mass in hypercholesterolemic rabbits
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1352 - H1358.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Sundstrom, J. C. Evans, E. J. Benjamin, D. Levy, M. G. Larson, D. B. Sawyer, D. A. Siwik, W. S. Colucci, P. W.F. Wilson, and R. S. Vasan
Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study
Eur. Heart J., September 1, 2004; 25(17): 1509 - 1516.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K. Michaelsson, H. Lithell, B. Vessby, and H. Melhus
Serum Retinol Levels and the Risk of Fracture
N. Engl. J. Med., January 23, 2003; 348(4): 287 - 294.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Bjorklund, L. Lind, B. Vessby, B. Andren, and H. Lithell
Different Metabolic Predictors of White-Coat and Sustained Hypertension Over a 20-Year Follow-Up Period: A Population-Based Study of Elderly Men
Circulation, July 2, 2002; 106(1): 63 - 68.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Verdecchia, C. Porcellati, G. Reboldi, R. Gattobigio, C. Borgioni, T. A. Pearson, and G. Ambrosio
Left Ventricular Hypertrophy as an Independent Predictor of Acute Cerebrovascular Events in Essential Hypertension
Circulation, October 23, 2001; 104(17): 2039 - 2044.
[Abstract] [Full Text] [PDF]